Since whooping cough is a toxin-mediated disease and PT is the central factor that promotes severity of the disease, PT is a promising target for development of novel pharmacological strategies against severe pertussis in infants, and also against cough symptomology in older patients with pertussis. Here, F2 is linked to pertussis.